Cargando…

Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches

Hepatocellular carcinoma (HCC) still represents a significant complication of chronic liver disease, particularly when cirrhosis ensues. Current treatment options include surgery, loco-regional procedures and chemotherapy, according to specific clinical practice guidelines. Immunotherapy with check-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantovani, Stefania, Oliviero, Barbara, Varchetta, Stefania, Mele, Dalila, Mondelli, Mario U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226319/ https://www.ncbi.nlm.nih.gov/pubmed/32283827 http://dx.doi.org/10.3390/cancers12040926

Ejemplares similares

Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
por: Mondelli, Mario U., et al.
Publicado: (2012)

Impaired intratumoral natural killer cell function in head and neck carcinoma
por: Mele, Dalila, et al.
Publicado: (2022)

Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection
por: Cerino, Antonella, et al.
Publicado: (2019)

Expansion of atypical memory B cells is a prominent feature of COVID-19
por: Oliviero, Barbara, et al.
Publicado: (2020)

TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
por: Mantovani, Stefania, et al.
Publicado: (2023)

Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells
por: Mantovani, Stefania, et al.
Publicado: (2022)

Unique immunological profile in patients with COVID-19
por: Varchetta, Stefania, et al.
Publicado: (2020)

High Frequencies of Functional Virus-Specific CD4(+) T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders
por: Mele, Dalila, et al.
Publicado: (2021)

An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma
por: Mantovani, Stefania, et al.
Publicado: (2020)

Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)

Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
por: Kalathil, Suresh Gopi, et al.
Publicado: (2021)

MICA/B-targeted antibody promotes NK cell–driven tumor immunity in patients with intrahepatic cholangiocarcinoma
por: Oliviero, Barbara, et al.
Publicado: (2022)

Novel natural killer cell-mediated cancer immunotherapeutic activity of anisomycin against hepatocellular carcinoma cells
por: Kim, Miok, et al.
Publicado: (2018)

Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4(pos) T cells and macrophages
por: Varchetta, Stefania, et al.
Publicado: (2013)

Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma
por: Shen, Wanying, et al.
Publicado: (2022)

Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytes
por: Oliviero, Barbara, et al.
Publicado: (2023)

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
por: Bottino, Cristina, et al.
Publicado: (2014)

Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents
por: Carreño, Leandro J, et al.
Publicado: (2016)

Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications
por: Sung, Pil Soo, et al.
Publicado: (2018)

Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors
por: Tarke, Alison, et al.
Publicado: (2022)

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies
por: Chouaib, Salem, et al.
Publicado: (2014)

Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma
por: Devan, Aswathy R., et al.
Publicado: (2021)

Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma
por: Zhang, Kai, et al.
Publicado: (2023)

Engagement of Siglec-7 Receptor Induces a Pro-Inflammatory Response Selectively in Monocytes
por: Varchetta, Stefania, et al.
Publicado: (2012)

The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
por: Daly, John, et al.
Publicado: (2019)

Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure
por: Schober, Rafaëla, et al.
Publicado: (2023)

Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
por: Koh, Benjamin, et al.
Publicado: (2023)

Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategy
por: Palermo, Belinda, et al.
Publicado: (2005)

Implications of m6A-associated snRNAs in the prognosis and immunotherapeutic responses of hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2022)

A Novel Prognostic Signature Associated with Immunotherapeutic Response for Hepatocellular Carcinoma
por: Jin, Xinmin, et al.
Publicado: (2022)

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody
por: Patel, Nishant P., et al.
Publicado: (2020)

The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: Bertino, Gaetano, et al.
Publicado: (2015)

A novel natural killer-related signature to effectively predict prognosis in hepatocellular carcinoma
por: Xi, Deyang, et al.
Publicado: (2023)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma
por: Bann, Darrin V., et al.
Publicado: (2016)

Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review
por: Chan, Alvin Man Lung, et al.
Publicado: (2023)

Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: BioMed Research International,
Publicado: (2016)

Development and validation of a prognostic and immunotherapeutically relevant model in hepatocellular carcinoma
por: Wang, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_il3h7h6isa0toi1m82vv3g9ugu